609 related articles for article (PubMed ID: 23978327)
1. Influenza virus hemagglutinin stalk-based antibodies and vaccines.
Krammer F; Palese P
Curr Opin Virol; 2013 Oct; 3(5):521-30. PubMed ID: 23978327
[TBL] [Abstract][Full Text] [Related]
2. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.
Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; García-Sastre A; Albrecht RA
J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585
[TBL] [Abstract][Full Text] [Related]
3. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
4. Novel universal influenza virus vaccine approaches.
Krammer F
Curr Opin Virol; 2016 Apr; 17():95-103. PubMed ID: 26927813
[TBL] [Abstract][Full Text] [Related]
5. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.
Krammer F; Pica N; Hai R; Margine I; Palese P
J Virol; 2013 Jun; 87(12):6542-50. PubMed ID: 23576508
[TBL] [Abstract][Full Text] [Related]
6. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
[TBL] [Abstract][Full Text] [Related]
7. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.
Krammer F; Palese P
J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353
[TBL] [Abstract][Full Text] [Related]
8. The influenza virus hemagglutinin head evolves faster than the stalk domain.
Kirkpatrick E; Qiu X; Wilson PC; Bahl J; Krammer F
Sci Rep; 2018 Jul; 8(1):10432. PubMed ID: 29992986
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
10. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
11. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes.
Hai R; Krammer F; Tan GS; Pica N; Eggink D; Maamary J; Margine I; Albrecht RA; Palese P
J Virol; 2012 May; 86(10):5774-81. PubMed ID: 22398287
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
Ramírez-Salinas GL; García-Machorro J; Rojas-Hernández S; Campos-Rodríguez R; de Oca AC; Gomez MM; Luciano R; Zimic M; Correa-Basurto J
Arch Virol; 2020 Apr; 165(4):891-911. PubMed ID: 32060794
[TBL] [Abstract][Full Text] [Related]
13. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
15. A highly conserved neutralizing epitope on group 2 influenza A viruses.
Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
[TBL] [Abstract][Full Text] [Related]
16. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
Margine I; Krammer F; Hai R; Heaton NS; Tan GS; Andrews SA; Runstadler JA; Wilson PC; Albrecht RA; García-Sastre A; Palese P
J Virol; 2013 Oct; 87(19):10435-46. PubMed ID: 23903831
[TBL] [Abstract][Full Text] [Related]
17. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination strategies targeting the hemagglutinin stem region.
Fukuyama H; Shinnakasu R; Kurosaki T
Immunol Rev; 2020 Jul; 296(1):132-141. PubMed ID: 32542739
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine.
Nagashima KA; Mousa JJ
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805245
[TBL] [Abstract][Full Text] [Related]
20. A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
Bliss CM; Nachbagauer R; Mariottini C; Cuevas F; Feser J; Naficy A; Bernstein DI; Guptill J; Walter EB; Berlanda-Scorza F; Innis BL; García-Sastre A; Palese P; Krammer F; Coughlan L
EBioMedicine; 2024 Jun; 104():105153. PubMed ID: 38805853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
